Exelixis
EXEL
#2109
Rank
ยฃ5.74 B
Marketcap
ยฃ20.13
Share price
-1.53%
Change (1 day)
15.14%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: ยฃ5.74 Billion

As of September 2024 Exelixis has a market cap of ยฃ5.74 Billion. This makes Exelixis the world's 2109th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2024

End of year Market Cap

Year Market cap Change
2024ยฃ5.74 B-1.94%
2023ยฃ5.85 B36.92%
2022ยฃ4.27 B0.07%
2021ยฃ4.27 B-6.3%
2020ยฃ4.56 B13.06%
2019ยฃ4.03 B-12.73%
2018ยฃ4.62 B-30.53%
2017ยฃ6.65 B89.96%
2016ยฃ3.50 B304.22%
2015ยฃ0.86 B378.29%
2014ยฃ0.18 B-73.54%
2013ยฃ0.68 B31.94%
2012ยฃ0.51 B25.71%
2011ยฃ0.41 B-29.19%
2010ยฃ0.58 B17.7%
2009ยฃ0.49 B34.77%
2008ยฃ0.36 B-18.79%
2007ยฃ0.45 B2.65%
2006ยฃ0.44 B-3.19%
2005ยฃ0.45 B22.66%
2004ยฃ0.37 B31.06%
2003ยฃ0.28 B-4.35%
2002ยฃ0.29 B-53.96%
2001ยฃ0.64 B40.55%
2000ยฃ0.45 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Exelixis was reported to be:

ยฃ5.74 Billion
by Yahoo Finance info icon info icon
ยฃ5.74 Billion
by CompaniesMarketCap info icon info icon
ยฃ5.74 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
ยฃ64.34 B 1,020.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ110.08 B 1,816.99%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ226.30 B 3,840.94%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ76.32 B 1,229.21%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ138.13 B 2,305.46%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ301.10 B 5,143.55%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ127.02 B 2,112.13%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ26.92 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.39 B-93.08%๐Ÿ‡บ๐Ÿ‡ธ USA